Paper51344
Shedding of infectious virus/antibody complexes from vesicular lesions of patients with recurrent herpes labialis.
Daniels CA and 1 other. Lancet, 1975. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Shedding of infectious virus/antibody complexes from vesicular lesions of patients with recurrent herpes labialis. Papers, record 51344. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/51344
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Shedding of infectious virus/antibody complexes from vesicular lesions of patients with recurrent herpes labialis.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Viral | Major topic |
| Herpes Labialis | Major topic |
| Simplexvirus | Major topic |
| Antibodies, Anti-Idiotypic | |
| Complement System Proteins | |
| Female | |
| Humans | |
| Male | |
| Neutralization Tests | |
| Recurrence |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23776340 | Application and tolerability of Herpotherm(®) in the treatment of genital herpes. | Clin Cosmet Investig Dermatol | 2013 | https://conductscience.org/library/papers/23776340 | PubMed |
| 21889905 | Current management and recommendations for access to antiviral therapy of herpes labialis. | J Clin Virol | 2012 | https://conductscience.org/library/papers/21889905 | PubMed |
| 7416235 | Scanning and transmission electron microscopic studies of complement-mediated lysis and antibody-dependent cell-mediated cytolysis of herpes simplex virus-infected human fibroblasts. | Am J Pathol | 1980 | https://conductscience.org/library/papers/7416235 | PubMed |
| 7016915 | Comparison of fluorescent-antibody, neutralizing-antibody, and complement-enhanced neutralizing-antibody assays for detection of serum antibody to respiratory syncytial virus. | J Clin Microbiol | 1981 | https://conductscience.org/library/papers/7016915 | PubMed |
| 6284091 | Neutralising antibody in mice with primary and recurrent herpes simplex virus infection. | Arch Virol | 1982 | https://conductscience.org/library/papers/6284091 | PubMed |
| 6164273 | Persistent viral infections as models for research in virus chemotherapy. | Adv Virus Res | 1981 | https://conductscience.org/library/papers/6164273 | PubMed |
| 1085748 | Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses. | Infect Immun | 1976 | https://conductscience.org/library/papers/1085748 | PubMed |
| 218539 | Enhanced antiglobulin-mediated neutralization of herpes simplex virus-IgG complexes by complement and heterologous anti-immunoglobulin. | Arch Virol | 1979 | https://conductscience.org/library/papers/218539 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/51344
GET https://conductscience.org/api/papers/v1/51344/authors